ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

alnylam netherlands b.v. - patisiran natrija - Амилоидоз, obiteljska - ostali lijekovi protiv živčanog sustava - onpattro indiciran za liječenje nasljednih транстиретина-посредничанного амилоидоза (hattr амилоидоз) u odraslih bolesnika s fazi 1 ili 2 fazi полинейропатии.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

akcea therapeutics ireland limited - inotersen natrija - amiloidoza - ostali lijekovi protiv živčanog sustava - liječenje 1 faza ili faza 2 полинейропатии kod odraslih pacijenata s nasljednim транстиретина амилоидоз (hattr).

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

viiv healthcare b.v. - долутегравир natrija, рилпивирин hidroklorid - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - juluca indiciran za liječenje virusa humane imunodeficijencije tipa 1 (hiv-1) infekcije kod odraslih, koji вирусологически.-potisnuta (hiv-1 rna.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

akcea therapeutics ireland limited - volanesorsen natrija - hyperlipoproteinemia type i - drugi гиполипидемические modificiranje - waylivra prikazan kao dodatak prehrani kod odraslih pacijenata s genetski potvrdio obiteljska chylomicronemia sindrom (dvs) i visok rizik za razvoj pankreatitis, u kojima je odgovor na prehrane i trigliceridi антигипертензивная terapija je bila neadekvatna.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

scipharm sàrl - treprostinil natrija - hipertenzija, plućna - antitrombotska sredstva - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - monohidrat Имипенем, циластатин natrija, relebactam monohidrat - Грамотрицательные bakterijske infekcije - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 i 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - etorikoksib - filmom obložena tableta - 120 mg - urbroj: svaka filmom obložena tableta sadrži 120 mg etorikoksiba

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - etorikoksib - filmom obložena tableta - 30 mg - urbroj: svaka filmom obložena tableta sadrži 30 mg etorikoksiba

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - etorikoksib - filmom obložena tableta - 60 mg - urbroj: svaka filmom obložena tableta sadrži 60 mg etorikoksiba

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - etorikoksib - filmom obložena tableta - 90 mg - urbroj: svaka filmom obložena tableta sadrži 90 mg etorikoksiba